Psycheceutical

12/19/2023

Recent studies suggest that the psychological and physiological effects of psychedelics may contribute to their therapeutic effects — even in non-psychedelic doses. ⁠

⁠Read more in Scientific American as researchers explore the therapeutic potential of psychedelics and whether the traditional "trip" experience is necessary for their medicinal benefits. ⁠

Psychedelic researchers are engaged in heated debate over whether the mind-altering effects of the drugs are necessary for realizing their therapeutic potential.

11/27/2023

We're proud to be sponsors of the upcoming Kentucky Summit on Exploring Breakthrough Therapeutic Potential for OUD - a groundbreaking event dedicated to fostering collaboration in the fight against opioid use disorder.

🤝 Join us in bringing together practitioners, healthcare providers, treatment centers, caregivers, policy makers, life sciences companies, and community members in a shared mission is to explore new avenues of treatment, share insights, and collectively strive for positive change.

🌐 This summit is not just an event; it's a movement towards a world where individuals affected by opioid use disorder receive the support they need.

💙 Together, we can forge a path towards a future free from the grip of opioid use disorder.

Event details:

November 30, 2023 | CityPlace | La Grange, KY

11/17/2023

Don't miss our latest feature in Express Pharma, where Dr. Ronald Aung-din and Dr. Aric Logsdon discuss the importance of safe and effective delivery of psychedelic medicines, and how our NeuroDirect™ technology is designed to reduce the complexity of drug delivery across the blood-brain barrier.

https://issuu.com/indianexpressgroup/docs/ep_november_2023/16

11/15/2023

The Atlantic explores a new generation of non-hallucinogenic psychedelics aiming to transform clinical therapy and offer new hope for mental health treatment.

"Trip-free psychedelics would be a great therapeutic boon, dramatically expanding the number of people who can experience the benefits of these drugs. They might also shed new light on how much psychedelics can alleviate psychic distress—and why they do so at all."

Dive into the article: https://www.theatlantic.com/health/archive/2023/11/non-hallucinogenic-psychedelic-clinical-therapy/675942/

11/10/2023

Join Psychedelic Spotlight for a closer look at the NeuroDirect™ topical ketamine formula and its potential for treating individuals suffering from Post-Traumatic Stress Disorder (PTSD).

https://psychedelicspotlight.com/ketamine-topical-ptsd/

Anecdotal research suggests NeuroDirect topical ketamine relieves PTSD symptoms in minutes. But the mechanism of action is unclear.

11/06/2023

Don't miss our latest feature in Benzinga to learn more about our crowdfunding campaign, and our lead investor, an original shark from Shark Tank, Kevin Harrington!

https://www.benzinga.com/general/biotech/23/11/35618432/shark-tanks-kevin-harrington-leads-crowdfunding-campaign-for-psycheceutical-bioscience-otcpk-bwvi

Shark Tank’s Kevin Harrington thinks safe psychedelic medicines without the “trip” are the future of mental health care, and has put his support behind Psycheceutical - Click Here To Invest

11/02/2023

Our community crowdfunding campaign on Wefunder is now live! Invest and be a part of our vision for the future of treatment.

Invest at: https://wefunder.com/psycheceutical

10/30/2023

: Watch Psycheceutical CEO Chad Harman interviewed by Raging Bull Trading's Jeff Bishop on how the company is using cutting-edge technologies in next-generation mental health treatments.

Full Interview Here: https://www.youtube.com/watch?v=NjUwa8yD55s

10/27/2023

The polls are open for Microdose's Third Annual Wonderland Awards, and we're thrilled to be nominated once again in the B2B Tech Company of the Year category!

Help us win by voting once per day until November 3, and thank you for the continued incredible support!

Click here to vote each day.

Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds for the next generation of mental health treatment.

10/18/2023

Episode 1 of the Department of Veterans Affairs' new podcast, "New Horizons in Health: Bringing Veteran Health Care into the Future," delves into the healing potential of psychedelic-assisted therapy, featuring expert commentary and a veteran's powerful and transformative story.

Watch or listen: https://www.youtube.com/watch?v=gxKuqYgeKh4

10/11/2023

Want to stay in the loop with the latest news, insights, and updates from the Psycheceutical team? Be sure to join our community by signing up for our newsletter!

Subscribe Here: https://psycheceutical.com/newsletter-subscribe/

10/10/2023

Dive into the potential of topical ketamine as a promising avenue for treating PTSD with our latest feature in Pharmacy Times.

Exploring the use of ketamine in topical form, via Psycheceutical's NeuroDirect™ topical delivery system, and its potential to provide effective relief for individuals struggling with PTSD, the article delves into how this innovative approach could pave the way for improved mental health treatment.

https://www.pharmacytimes.com/view/topical-ketamine-a-promising-new-avenue-for-ptsd-treatment